Advertisement

Intervillous Space: Infiltrates

  • Adrian K. CharlesEmail author
  • Marie-Anne Bründler
Chapter

Abstract

Histological lesions involving the intervillous space include inflammatory and infectious diseases covered elsewhere, maternal malignancies, maternal haematological disease and trophoblastic lesions including choriocarcinoma. Placental involvement by maternal malignancies is uncommon, but likely under-reported as the lesions often are not visible on macroscopic examination, and may mimic infarcts or other benign lesions such as perivillous fibrin with intermediate trophoblast. Mostly they arise from haematogenous spread, but direct tumour extension is also reported. Malignant melanoma is the most common tumour to spread, followed by lung and breast cancer and leukaemia/lymphoma. Maternal metastasis involves the intervillous space and, in a small proportion of cases, chorionic villous invasion with or without vascular invasion is also present. Fetal/infant metastasis is rare. Malignant tumour cell spread to the conceptus has to be compared to the increasing recognition of the role of two-way benign cell transfer causing microchimerism of the mother and fetus in both maternal and childhood diseases. A number of cases with placental metastases appear associated with stillbirth due to many possible causes but only rarely due to fetal metastases.

Keywords

Maternal malignancy Placental metastasis Fetal metastasis Intervillous space Chorionic villi Malignant melanoma Leukaemia Maternal cancer 

References

  1. 1.
    Al-Adnani M, Kiho L, Scheimberg I. Maternal pancreatic carcinoma metastatic to the placenta: a case report and literature review. Pediatr Dev Pathol. 2007;10:61–5.CrossRefGoogle Scholar
  2. 2.
    van der Velden VH, Willemse MJ, Mulder MF, Szczepański T, Langerak AW, Wijkhuijs JM, et al. Clearance of maternal leukaemic cells in a neonate. Br J Haematol. 2001;114:104–6.CrossRefGoogle Scholar
  3. 3.
    Broestl L, Rubin JB, Dahiya S. Fetal microchimerism in human brain tumors. Brain Pathol. 2017;  https://doi.org/10.1111/bpa.12557.CrossRefGoogle Scholar
  4. 4.
    Gammill HS, Harrington WE. Microchimerism: defining and redefining the prepregnancy context—a review. Placenta. 2017;  https://doi.org/10.1016/j.placenta.2017.08.071.CrossRefGoogle Scholar
  5. 5.
    Kinder JM, Stelzer IA, Arck PC, Way SS. Immunological implications of pregnancy-induced microchimerism. Nat Rev Immunol. 2017;17:483–94.CrossRefGoogle Scholar
  6. 6.
    Altman JF, Lowe L, Redman B, Esper P, Schwartz JL, Johnson TM, et al. Placental metastasis of maternal melanoma. J Am Acad Dermatol. 2003;49:1150–4.CrossRefGoogle Scholar
  7. 7.
    Baergen RN, Johnson D, Moore T, Benirschke K. Maternal melanoma metastatic to the placenta: a case report and review of the literature. Arch Pathol Lab Med. 1997;121:508–11.PubMedGoogle Scholar
  8. 8.
    Alexander A, Samlowski WE, Grossman D, Bruggers CS, Harris RM, Zone JJ, et al. Metastatic melanoma in pregnancy: risk of transplacental metastases in the infant. J Clin Oncol. 2003;21:2179–86.CrossRefGoogle Scholar
  9. 9.
    Pavlidis N, Pentheroudakis G. Metastatic involvement of placenta and fetus in pregnant women with cancer. Recent Results Cancer Res. 2008;178:183–94.CrossRefGoogle Scholar
  10. 10.
    Voulgaris E, Pentheroudakis G, Pavlidis N. Cancer and pregnancy. A comprehensive review. Surg Oncol. 2011;20:e175–85.CrossRefGoogle Scholar
  11. 11.
    De Carolis S, Garofalo S, Degennaro VA, Zannoni GF, Salvi S, Moresi S, et al. Placental and infant metastasis of maternal melanoma: a new case. J Obstet Gynaecol. 2015;35:417–8.CrossRefGoogle Scholar
  12. 12.
    Menada MV, Moioli M, Garaventa A, Nozza P, Foppiano M, Trimarchi N, et al. Spontaneous regression of transplacental metastases from maternal melanoma in a newborn: case report and review of the literature. Melanoma Res. 2010;20:443–9.CrossRefGoogle Scholar
  13. 13.
    Brossard J, Abish S, Bernstein ML, Baruchel S, Kovacs L, Pollack R. Maternal malignancy involving the products of conception: a report of malignant melanoma and medulloblastoma. Am J Pediatr Hematol Oncol. 1994;16:380–3.PubMedGoogle Scholar
  14. 14.
    Ackerman J, Gilbert-Barness E. Malignancy metastatic to the products of conception: a case report with literature review. Pediatr Pathol Lab Med. 1997;17:577–86.CrossRefGoogle Scholar
  15. 15.
    Boussios S, Han SN, Fruscio R, Halaska MJ, Ottevanger PB, Peccatori FA, et al. Lung cancer: report of nine cases from an international collaborative study. Lung Cancer. 2013;82:499–505.CrossRefGoogle Scholar
  16. 16.
    Jackisch C, Louwen F, Schwenkhagen A, Karbowski B, Schmid KW, Schneider HP, et al. Lung cancer during pregnancy involving the products of conception and a review of the literature. Arch Gynecol Obstet. 2003;268:69–77.PubMedGoogle Scholar
  17. 17.
    Azim HA Jr, Peccatori FA, Pavlidis N. Lung cancer in the pregnant woman: to treat or not to treat, that is the question. Lung Cancer. 2010;67:251–6.CrossRefGoogle Scholar
  18. 18.
    Tolar J, Coad JE, Neglia JP. Transplacental transfer of small-cell carcinoma of the lung. N Engl J Med. 2002;346:1501–2.CrossRefGoogle Scholar
  19. 19.
    Folk JJ, Curioca J, Nosovitch JT Jr, Silverman RK. Poorly differentiated large cell adenocarcinoma of the lung metastatic to the placenta: a case report. J Reprod Med. 2004;49:395–7.PubMedGoogle Scholar
  20. 20.
    Sheikh SS, Khalifa MA, Marley EF, Bagg A, Lage JM. Acute monocytic leukemia (FAB M5) involving the placenta associated with delivery of a healthy infant: case report and discussion. Int J Gynecol Pathol. 1996;15:363–6.CrossRefGoogle Scholar
  21. 21.
    Horowitz NA, Benyamini N, Wohlfart K, Brenner B, Avivi I. Reproductive organ involvement in non-Hodgkin lymphoma during pregnancy: a systematic review. Lancet Oncol. 2013;14:e275–82.CrossRefGoogle Scholar
  22. 22.
    Maruko K, Maeda T, Kamitomo M, Hatae M, Sueyoshi K. Transplacental transmission of maternal B-cell lymphoma. Am J Obstet Gynecol. 2004;191:380–1.CrossRefGoogle Scholar
  23. 23.
    Meguerian-Bedoyan Z, Lamant L, Hopfner C, Pulford K, Chittal S, Delsol G. Anaplastic large cell lymphoma of maternal origin involving the placenta: case report and literature survey. Am J Surg Pathol. 1997;21:1236–41.CrossRefGoogle Scholar
  24. 24.
    Pollack RN, Sklarin NT, Rao S, Divon MY. Metastatic placental lymphoma associated with maternal human immunodeficiency virus infection. Obstet Gynecol. 1993;81:856–7.PubMedGoogle Scholar
  25. 25.
    Kurtin PJ, Gaffey TA, Habermann TM. Peripheral T-cell lymphoma involving the placenta. Cancer. 1992;70:2963–8.CrossRefGoogle Scholar
  26. 26.
    Herskovic E, Ryan M, Weinstein J, Wadhwani NR. Maternal to fetal transmission of cervical carcinoma. Pediatr Radiol. 2014;44:1035–8.CrossRefGoogle Scholar
  27. 27.
    Momeni M, Cantu J, Young AE. Placental abruption and fetal demise secondary to placental metastases from unknown primary: a case report. J Reprod Med. 2013;58:341–3.PubMedGoogle Scholar
  28. 28.
    Pavlidis N, Peccatori FA, Lofts F, Greco AF. Cancer of unknown primary during pregnancy: an exceptionally rare coexistence. Anticancer Res. 2015;35:575–9.PubMedGoogle Scholar
  29. 29.
    Dessolle L, Dalmon C, Roche B, Daraï E. Placental metastases from maternal malignancies: review of the literature. J Gynecol Obstet Biol Reprod (Paris). 2007;36:344–53.CrossRefGoogle Scholar
  30. 30.
    Dessolle L, Dalmon C, Roche B, Menain N, Daraï E. Placental metastases from a maternal squamous cell tumor of the maxillary. Eur J Obstet Gynecol Reprod Biol. 2005;123:117–8.CrossRefGoogle Scholar
  31. 31.
    Jeong B, Shim JY, Kim CJ, Won HS, Lee PR, Kim A. Massive perivillous fibrin deposition in the placenta and uterine metastasis of gastric adenocarcinoma during pregnancy. J Obstet Gynaecol Res. 2014;40:1150–3.CrossRefGoogle Scholar
  32. 32.
    Aker S, Katlan DC, Yüce T, Söylemez F. Placental hepatic, and supraclavicular lymph node metastasis in pancreatic adenocarcinoma during pregnancy: a case report. Turk J Obstet Gynecol. 2016;13:161–3.CrossRefGoogle Scholar
  33. 33.
    Heller DS, Hatem F. Endometrial stromal neoplasm in the placenta: report of a case and review of the literature. Int J Gynecol Pathol. 2018;37:32–4.PubMedGoogle Scholar
  34. 34.
    Sakurai H, Mitsuhashi N, Ibuki Y, Joshita T, Fukusato T, Niibe H. Placental metastasis from maternal primitive neuroectodermal tumor. Am J Clin Oncol. 1998;21:39–41.CrossRefGoogle Scholar
  35. 35.
    Kishkurno S, Ishida A, Takahashi Y, Arai H, Nakajima W, Abe T, Takada G. A case of neonatal choriocarcinoma. Am J Perinatol. 1997;14:79–82.CrossRefGoogle Scholar
  36. 36.
    Picton SV, Bose-Haider B, Lendon M, Hancock BW, Campbell RH. Simultaneous choriocarcinoma in mother and newborn infant. Med Pediatr Oncol. 1995;25:475–8.CrossRefGoogle Scholar
  37. 37.
    Bloomfield RD, Suarez JR, Malangit AC. The placenta: a diagnostic tool in sickle cell disorders. J Natl Med Assoc. 1978;70:87–8.PubMedPubMedCentralGoogle Scholar
  38. 38.
    Trampont P, Roudier M, Andrea AM, Nomal N, Mignot TM, Leborgne-Samuel Y, Ravion S, Clayton J, Mary D, Elion J, Decastel M. The placental-umbilical unit in sickle cell disease pregnancy: a model for studying in vivo functional adjustments to hypoxia in humans. Hum Pathol. 2004;35:1353–9.CrossRefGoogle Scholar
  39. 39.
    Weibull CE, Eloranta S, Smedby KE, Björkholm M, Kristinsson SY, Johansson AL, Dickman PW, Glimelius I. Pregnancy and the risk of relapse in patients diagnosed with Hodgkin lymphoma. J Clin Oncol. 2016;34:337–44.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Sidra MedicineDohaQatar
  2. 2.Weill Cornell Medical CollegeDohaQatar
  3. 3.Department of Pathology and Laboratory Medicine and Paediatrics, Cumming School of MedicineUniversity of CalgaryCalgaryCanada
  4. 4.Department of Pathology and Laboratory MedicineAlberta Children’s HospitalCalgaryCanada

Personalised recommendations